Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MKP10241 in obesity and type 2 diabetes
NCT07098663Phase 2Recruiting
- Sponsor
- Mankind Pharma
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MKP10241 in type 2 diabetes mellitus (T2DM), obesity, sponsored by Mankind Pharma. Started Aug 2025; status: recruiting.
02
Drugs
MKP10241
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT07098663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07098663.